澳华内镜
(688212)
| 流通市值：69.33亿 | | | 总市值：69.33亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 500,553,520.06 | 353,524,229.81 | 169,298,973.87 | 678,080,728.03 |
| 营业收入 | 500,553,520.06 | 353,524,229.81 | 169,298,973.87 | 678,080,728.03 |
| 二、营业总成本 | 504,921,469.56 | 371,843,932.97 | 176,934,143.33 | 651,784,049.3 |
| 营业成本 | 153,910,636.66 | 100,909,672.24 | 39,947,162.82 | 177,766,731.9 |
| 税金及附加 | 4,017,763.37 | 2,685,063.23 | 1,526,965.62 | 6,420,973.19 |
| 销售费用 | 159,507,236.16 | 122,623,118.18 | 63,575,643.44 | 232,366,685.77 |
| 管理费用 | 74,775,177.3 | 58,682,045.76 | 27,757,255.01 | 90,866,327.91 |
| 研发费用 | 113,108,128.27 | 87,336,827.97 | 44,482,962.56 | 146,996,191.31 |
| 财务费用 | -397,472.2 | -392,794.41 | -355,846.12 | -2,632,860.78 |
| 其中:利息费用 | 945,037.45 | 332,423.93 | 134,145.39 | 695,104.49 |
| 其中:利息收入 | 1,810,216.01 | 776,653.11 | 577,003.76 | 2,976,081.1 |
| 加:公允价值变动收益 | 4,604,982.93 | 3,930,867.61 | 2,152,420.11 | 7,907,037.6 |
| 加:投资收益 | 3,952,895.62 | 2,612,673.66 | 1,238,833.69 | 3,636,348.02 |
| 资产处置收益 | 155,585.46 | 150,881.07 | 31,176.78 | -749,103.04 |
| 资产减值损失(新) | -4,201,136.28 | -2,785,445.75 | -2,036,390.78 | -18,017,568.37 |
| 信用减值损失(新) | -9,957,624.64 | -7,564,626.39 | -4,790,907.24 | -7,845,385.55 |
| 其他收益 | 40,381,370.09 | 19,877,800.17 | 10,724,362.85 | 43,111,534.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 30,568,123.68 | -2,097,552.79 | -315,674.05 | 54,339,541.92 |
| 加:营业外收入 | 4,324.07 | 4,112.59 | 643.07 | 3,990.47 |
| 减:营业外支出 | 484,230.51 | 294,859.69 | 700 | 433,304.98 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 30,088,217.24 | -2,388,299.89 | -315,730.98 | 53,910,227.41 |
| 减:所得税费用 | -6,870,136.43 | -7,960,328.61 | -2,869,603.72 | -6,863,887.12 |
| 六、净利润 | 36,958,353.67 | 5,572,028.72 | 2,553,872.74 | 60,774,114.53 |
| 持续经营净利润 | 36,958,353.67 | 5,572,028.72 | 2,553,872.74 | 60,774,114.53 |
| 归属于母公司股东的净利润 | 37,303,031.49 | 5,661,627.44 | 2,759,505.2 | 57,854,368.15 |
| 少数股东损益 | -344,677.82 | -89,598.72 | -205,632.46 | 2,919,746.38 |
| (一)基本每股收益 | 0.28 | 0.04 | 0.02 | 0.43 |
| (二)稀释每股收益 | 0.28 | 0.04 | 0.02 | 0.43 |
| 八、其他综合收益 | -229,909.45 | -1,409,777.16 | -1,299,385.97 | 3,027,275.12 |
| 归属于母公司股东的其他综合收益 | -229,909.45 | -1,409,777.16 | -1,299,385.97 | 3,027,275.12 |
| 九、综合收益总额 | 36,728,444.22 | 4,162,251.56 | 1,254,486.77 | 63,801,389.65 |
| 归属于母公司股东的综合收益总额 | 37,073,122.04 | 4,251,850.28 | 1,460,119.23 | 60,881,643.27 |
| 归属于少数股东的综合收益总额 | -344,677.82 | -89,598.72 | -205,632.46 | 2,919,746.38 |
| 公告日期 | 2024-10-25 | 2024-08-23 | 2024-04-30 | 2024-04-10 |
| 审计意见(境内) | | | | 标准无保留意见 |